Solid Tumor Genomics Profiling-Liquid Biopsy

Overview:

IGB offers oncomine next-generation sequencing (NGS) solutions for liquid biopsy research can provide detailed insights with precision and speed, from just a single tube of blood. Oncomine Cell-Free Nucleic Acid (cfNA) liquid biopsy assays are highly sensitive, multi-biomarker NGS assays that enable molecular insights into tumor evolution and detection of primary driver and resistance mutations for clinical research. With a single tube of blood, you can go from sample to complete variant report in days, not weeks. Oncomine cfNA assays enable you to deliver a relevant genomic profile even if a tissue sample is unavailable, or complement tissue testing to understand tumor heterogeneity.

 

Assay Options:

 

Our Resources

Oncomine Solutions

Solid Tumor Genomics Profiling - Liquid Biopsy

Let’s Connect with Expert

From time to time, we may contact you about our products, services, and other content that may be of interest to you. If you would like to receive such communications, please provide your consent below:

+91 8971097244
contactus@igbiosystems.com